Global Trust Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $392K | Sell |
8,167
-8,608
| -51% | -$370K | 0.12% | 98 |
|
|
2026
Q1 | $616K | Sell |
16,775
-1,570
| -9% | -$74.4K | 0.24% | 72 |
|
|
2025
Q4 | $933K | Sell |
18,345
-2,978
| -14% | -$152K | 0.37% | 56 |
|
|
2025
Q3 | $1.18M | Sell |
21,323
-1,000
| -4% | -$58.5K | 0.54% | 43 |
|
|
2025
Q2 | $1.54M | Sell |
22,323
-2,973
| -12% | -$202K | 0.82% | 26 |
|
|
2025
Q1 | $1.76M | Sell |
25,296
-558
| -2% | -$46.1K | 1.07% | 20 |
|
|
2024
Q4 | $2.22M | Sell |
25,854
-700
| -3% | -$75.7K | 0.84% | 28 |
|
|
2024
Q3 | $3.16M | Sell |
26,554
-173
| -0.6% | -$23.1K | 1.17% | 16 |
|
|
2024
Q2 | $3.82M | Hold |
26,727
| – | – | 1.54% | 11 |
|
|
2024
Q1 | $3.43M | Buy |
26,727
+358
| +1% | +$42.6K | 1.41% | 14 |
|
|
2023
Q4 | $2.73M | Buy |
26,369
+300
| +1% | +$29.7K | 1.2% | 15 |
|
|
2023
Q3 | $2.37M | Sell |
26,069
-1
| -0% | -$88 | 1.13% | 17 |
|
|
2023
Q2 | $2.11M | Sell |
26,070
-130
| -0.5% | -$10.6K | 0.95% | 22 |
|
|
2023
Q1 | $2.08M | Buy |
26,200
+70
| +0.3% | +$4.96K | 0.99% | 23 |
|
|
2022
Q4 | $1.77M | Hold |
26,130
| – | – | 0.89% | 28 |
|
|
2022
Q3 | $1.3M | Sell |
26,130
-426
| -2% | -$22.8K | 0.68% | 41 |
|
|
2022
Q2 | $1.48M | Sell |
26,556
-146
| -0.5% | -$8.1K | 0.73% | 40 |
|
|
2022
Q1 | $1.48M | Sell |
26,702
-150
| -0.6% | -$7.7K | 0.62% | 41 |
|
|
2021
Q4 | $1.5M | Hold |
26,852
| – | – | 0.59% | 42 |
|
|
2021
Q3 | $1.29M | Hold |
26,852
| – | – | 0.58% | 42 |
|
|
2021
Q2 | $1.13M | Sell |
26,852
-300
| -1% | -$11.6K | 0.54% | 46 |
|
|
2021
Q1 | $915K | Sell |
27,152
-570
| -2% | -$20.3K | 0.5% | 50 |
|
|
2020
Q4 | $968K | Hold |
27,722
| – | – | 0.53% | 44 |
|
|
2020
Q3 | $960K | Hold |
27,722
| – | – | 0.61% | 37 |
|
|
2020
Q2 | $908K | Hold |
27,722
| – | – | 0.63% | 36 |
|
|
2020
Q1 | $834K | Sell |
27,722
-500
| -2% | -$14.9K | 0.65% | 34 |
|
|
2019
Q4 | $817K | Sell |
28,222
-80
| -0.3% | -$2.21K | 0.49% | 56 |
|
|
2019
Q3 | $732K | Sell |
28,302
-1,450
| -5% | -$36.7K | 0.49% | 68 |
|
|
2019
Q2 | $759K | Sell |
29,752
-80
| -0.3% | -$1.98K | 0.51% | 62 |
|
|
2019
Q1 | $780K | Sell |
29,832
-180
| -0.6% | -$4.42K | 0.58% | 50 |
|
|
2018
Q4 | $691K | Sell |
30,012
-134
| -0.4% | -$2.98K | 0.62% | 47 |
|
|
2018
Q3 | $711K | Sell |
30,146
-1,000
| -3% | -$24.4K | 0.49% | 58 |
|
|
2018
Q2 | $718K | Hold |
31,146
| – | – | 0.54% | 54 |
|
|
2018
Q1 | $767K | Hold |
31,146
| – | – | 0.6% | 45 |
|
|
2017
Q4 | $836K | Buy |
+31,146
| New | +$792K | 0.59% | 46 |
|
Other funds holding NVO
F
Global Trust Asset Management's NVO Position: Q2 2026 in Review
Global Trust Asset Management reduced its Novo Nordisk (NVO) stake by 51% in Q2 2026, selling an estimated $370K and leaving 8,167 shares worth $392K. The position accounts for 0.12% of the portfolio, ranked #98.
Global Trust Asset Management first reported a position in NVO in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.82M in Q2 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Global Trust Asset Management held 8,167 shares of Novo Nordisk worth $392K as of Q2 2026.
- Global Trust Asset Management sold 8,608 Novo Nordisk shares in Q2 2026, an estimated $370K.
- Novo Nordisk made up 0.12% of Global Trust Asset Management's portfolio in Q2 2026, its #98 holding.
- Global Trust Asset Management first reported a position in Novo Nordisk in Q4 2017 and has held it in 35 quarters since.
- Global Trust Asset Management's Novo Nordisk position peaked at $3.82M in Q2 2024.
- 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.